logo

Teva Pharmaceutical Industries Limited (TEVA)



Trade TEVA now with
  Date
  Headline
2/5/2019 7:37:01 PM Teva Announces Launch Of ALYQ, Generic Version Of ADCIRCA In U.S.
2/1/2019 6:54:32 AM Teva Receives Positive CHMP Opinion For AJOVY For Prophylaxis Of Migraine In Adults
1/2/2019 8:29:33 PM Teva And Amgen Resolve Dispute Over Teva’s Generic Cinacalet HCl Product
12/27/2018 12:18:59 PM Teva Announces US Launch Of A Generic Version Of Elidel (Pimecrolimus) Cream, 1%
12/22/2018 11:53:30 AM Teva Pharma: FDA Approves ProAir Digihaler Inhalation Powder
12/17/2018 8:02:39 AM Teva Says FOCUS Study On Fremanezumab Met All Primary And Secondary Endpoints
12/5/2018 6:00:52 AM Citi Says Appointed As Successor Depositary Bank For Teva’s ADR Programme
11/1/2018 7:19:19 AM Teva Pharmaceutical Industries Limited (TEVA) Has Raised Its FY18 Revenue Estimate To $18.6 - $19.0 Bln From $18.5 - $19.0 Bln
11/1/2018 7:18:40 AM Teva Pharmaceutical Industries Limited (TEVA) Has Raised Its FY18 EPS Estimate To 2.80 - 2.95 From 2.55 - 2.80
11/1/2018 7:01:29 AM Teva Q3 GAAP Loss Per Share Of $0.27; Non-GAAP EPS $0.68